Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Edge Medical Ventures is a medtech-focused venture studio and fund founded by the leadership team of MEDX Xelerator, Israel’s leading medical device incubator. Established to address critical clinical unmet needs, the organization focuses on the development and investment in breakthrough medical device technologies. Headquartered in the United States, specifically in the New Jersey area, Edge Medical Ventures operates with a mission to bridge Israeli innovation with the U.S. market.
The firm manages a fund size of $70 million, which was launched around 2024, and has made six investments to date. Edge Medical Ventures employs a hybrid model that combines a venture studio, EdgeLabs, which identifies unmet clinical needs, and a venture capital fund, EdgeMED, that invests in later-stage medtech companies. The firm emphasizes collaboration with strategic players and healthcare systems in the U.S. to support its portfolio companies in their transition to the U.S. market.
Edge Medical Ventures invests primarily in medical device companies at the clinical stage, targeting seed, Series A, and early Series B rounds. The fund typically invests between $1 million and $3 million per company, with follow-on reserves of $5 million to $6 million allocated for each investment. The firm emphasizes collaboration with strategic players, healthcare systems, and investors in the U.S. to facilitate the growth of its portfolio companies.
The investment strategy focuses on sectors such as vascular interventions, urology, gastrointestinal health, women's health, home treatment, imaging, and minimally invasive surgery. Edge Medical Ventures aims to address critical clinical unmet needs through its investments in breakthrough medical device technologies, ensuring that its portfolio companies can effectively transition into the U.S. market.
Edge Medical Ventures has a diverse portfolio of six companies, each addressing significant healthcare challenges:
These companies represent Edge Medical Ventures' commitment to investing in technologies that address critical healthcare needs and improve patient outcomes.
Gal Atarot: Co-founder and Managing Partner. Gal has extensive experience in the medical device industry, having previously served as a leader at MEDX Xelerator. He holds a background in engineering and business management.
Shai Policker: Co-founder and Managing Partner. Shai has a strong track record in medical technology investments and has been instrumental in developing the firm's strategic vision. He has a background in finance and entrepreneurship.
Noam Taichler: Co-founder and Managing Partner. Noam brings financial expertise to the team, having previously worked in investment banking and venture capital. He is responsible for overseeing the firm's financial operations.
Anya Eldan: Partner. Anya has a background in healthcare consulting and has worked with various startups in the medical device sector, providing strategic insights and operational support.
Dr. Stephen Solomon: Partner. Dr. Solomon is a medical professional with experience in clinical research and product development, contributing valuable insights into the firm's investment decisions.
Eileen Ke: Chief Commercial Officer. Eileen has a strong background in commercial strategy and business development within the healthcare sector, focusing on market access for portfolio companies.
To pitch Edge Medical Ventures, interested parties should send their proposals via email to info@edgemed.vc. The pitch deck should include a comprehensive overview of the technology, market analysis, competitive landscape, and team qualifications. Founders can expect a response within a few weeks, and warm introductions are preferred but not mandatory.
In recent months, Edge Medical Ventures has actively expanded its portfolio, making notable investments in innovative medical device technologies. Recent additions include **LibAirty** and **Exero Medical**, both of which focus on addressing critical healthcare solutions. The firm continues to identify and invest in companies that align with its mission of bridging Israeli medical innovations with the U.S. market.
As of October 2023, Edge Medical Ventures is on track to maintain its pace of approximately one new deal per year, reflecting its commitment to supporting emerging medical device technologies.
What are Edge Medical Ventures' investment criteria?
Edge Medical Ventures primarily invests in medical device companies at the clinical stage, focusing on seed, Series A, and early Series B rounds. The firm looks for innovative solutions that address critical clinical unmet needs, particularly in sectors such as vascular interventions, urology, and minimally invasive surgery.
How can startups apply or pitch to Edge Medical Ventures?
Startups interested in pitching to Edge Medical Ventures can send their proposals via email to info@edgemed.vc. It is advisable to include a detailed overview of the technology, market potential, and team background in the pitch deck.
What makes Edge Medical Ventures different from other VC firms?
Edge Medical Ventures differentiates itself by bridging Israeli medical device innovation with the U.S. market. The firm provides operational support for portfolio companies, leveraging its extensive network and expertise in the medical device industry to facilitate growth and collaboration with strategic partners.
What is the geographic scope of Edge Medical Ventures?
The firm primarily focuses on investments within the United States, specifically targeting companies that can benefit from the U.S. healthcare system and market.
What is the typical check size for investments?
Edge Medical Ventures typically invests between $1 million and $3 million per company, with additional follow-on reserves available for promising portfolio companies.
What kind of post-investment involvement does Edge Medical Ventures have?
Edge Medical Ventures provides operational support and strategic guidance to its portfolio companies, assisting them in navigating the U.S. market and connecting them with key industry players and healthcare systems.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.